Coloplast A/S

Equities

COLO B

DK0060448595

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe Europe Other stock markets 10:15:41 2024-04-25 am EDT			5-day change	1st Jan Change
912.2 ^DKK	-1.06%		+1.76%	+18.13%

Feb. 27	Certain B Shares of Coloplast A/S are subject to a Lock-Up Agreement Ending on 27-FEB-2024.	CI
Feb. 14	COLOPLAST : Q1 24: Many more positives beyond the margin beat

Coloplast A/S : Trading in Coloplast shares by board members, executives or associated persons

February 10, 2020 at 04:38 am EST

Coloplast A/S
Managers' Transactions Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

Please see enclosed pdf.

Attachment

10022020_trading_in_shares_NKG

Attachments:
10022020_trading_in_shares_NKG.pdf

Attachments

Original document
Permalink

Disclaimer

Coloplast A/S published this content on 10 February 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 10 February 2020 09:37:01 UTC

Latest news about Coloplast A/S

Certain B Shares of Coloplast A/S are subject to a Lock-Up Agreement Ending on 27-FEB-2024.	Feb. 26	CI
COLOPLAST : Q1 24: Many more positives beyond the margin beat	Feb. 14
Nordic Shares Moved Upward Friday; Kongsberg Gruppen Topped Leaders	Feb. 09	DJ
Global markets live: Tesco, Boeing, Roche, Exxon Mobil, PepsiCo...	Feb. 09
Transcript : Coloplast A/S, Q1 2024 Earnings Call, Feb 09, 2024	Feb. 09
European shares flat as higher yields counter earnings bump	Feb. 09	RE
European shares inch up on earnings bump, higher yields weigh	Feb. 09	RE
Coloplast Posts Growth in Fiscal Q1 Net Profit, Revenue	Feb. 09	MT
Coloplast Launches Peristeen Light for People with Bowel Disorders	Feb. 09	CI
Coloplast A/S Reports Earnings Results for the First Quarter Ended December 31, 2023	Feb. 09	CI
Coloplast A/S Reaffirms Earnings Guidance for the Fiscal Year 2023/24	Feb. 09	CI
Coloplast Rolls Out New Silicone Foam for Wound Care in US	Jan. 31	MT
Coloplast A/SLaunches Biatain® Silicone Fit for Pressure Injury Prevention and Wound Management in the US	Jan. 31	CI
Nordic Stocks Decreased Wednesday; Kone B Posted Biggest Loss	Jan. 17	DJ
COLOPLAST : EPS cut (2023: -12.9%, 2024: -14.7%)	Jan. 04
Coloplast A/S Approves the Distribution of Year-End Dividend	Dec. 07	CI
COLOPLAST : Q4 23: more misses than hits	Dec. 06
Sweden's Bactiguard Hires New CFO	Nov. 21	MT
Nordic Stocks Decreased Thursday; Okeanis Eco Tankers Took Biggest Hit	Nov. 09	DJ
Transcript : Coloplast A/S, 2023 Earnings Call, Nov 09, 2023	Nov. 09
European shares gain on earnings boost; investors await cues on policy outlook	Nov. 09	RE
Coloplast to Build EUR100 Million Intermittent Catheter Manufacturing Site in Portugal	Nov. 09	MT
Coloplast A/S Reports Earnings Results for the Fourth Quarter Ended September 30, 2023	Nov. 09	CI
Coloplast Books Higher FY23 Net Profit; Revenue Jumps	Nov. 09	MT
Coloplast Announces New Manufacturing Site in Portugal	Nov. 09	CI

Chart Coloplast A/S

Duration

Period

More charts

Company Profile

Coloplast A/S specializes in the design, manufacturing, and marketing of disposable medical products. Net sales break down by family of products as follows: - hygiene products (43.4%): urine bags, plugs, urinary testing systems and sets, etc.; - ostomy care products (36.8%): bags and equipment used following intestinal operations; - wound care and skincare products (11.9%): wound dressings, bandages, creams and gels; - voice and respiratory care products (7.9%): voice prostheses for speaking, adhesives, laryngectomy cannulas for breathing, hands-free speaking devices, etc. Net sales are distributed geographically as follows: Denmark (1.4%), the United States (21%), the United Kingdom (14%), France (10.8%) and other (52.8%).

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-07 - Q2 2024 Earnings Release

Related indices

STOXX EUROPE 600 (EUR)

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

COLOPLAST : Q1 24: Many more positives beyond the margin beat

February 14, 2024 at 11:08 am EST

More Strategies

Ratings for Coloplast A/S

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

922 DKK

Average target price

917.1 DKK

Spread / Average Target

-0.54%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Supplies

	1st Jan change	Capi.
COLOPLAST A/S	+18.13%	29.7B
SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED	-33.64%	2.9B
WINNER MEDICAL CO., LTD.	-9.29%	2.71B
INTCO MEDICAL TECHNOLOGY CO., LTD.	+2.61%	2.14B
HARTALEGA HOLDINGS	-0.74%	1.91B
HARBIN FUERJIA TECHNOLOGY CO., LTD.	-13.01%	1.84B
TOP GLOVE CORPORATION BHD.	-5.56%	1.42B
NAKANISHI INC.	-2.49%	1.26B
KANGJI MEDICAL HOLDINGS LIMITED	+3.72%	1.13B
KOSSAN RUBBER INDUSTRIES	+14.05%	1.13B

Medical Supplies